782 related articles for article (PubMed ID: 20159883)
1. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.
Moran LJ; Misso ML; Wild RA; Norman RJ
Hum Reprod Update; 2010; 16(4):347-63. PubMed ID: 20159883
[TBL] [Abstract][Full Text] [Related]
2. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression.
Kakoly NS; Khomami MB; Joham AE; Cooray SD; Misso ML; Norman RJ; Harrison CL; Ranasinha S; Teede HJ; Moran LJ
Hum Reprod Update; 2018 Jul; 24(4):455-467. PubMed ID: 29590375
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
[TBL] [Abstract][Full Text] [Related]
4. The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis.
Behboudi-Gandevani S; Amiri M; Bidhendi Yarandi R; Noroozzadeh M; Farahmand M; Rostami Dovom M; Ramezani Tehrani F
Clin Endocrinol (Oxf); 2018 Feb; 88(2):169-184. PubMed ID: 28930378
[TBL] [Abstract][Full Text] [Related]
5. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome.
Vrbikova J; Dvorakova K; Grimmichova T; Hill M; Stanicka S; Cibula D; Bendlova B; Starka L; Vondra K
Clin Chem Lab Med; 2007; 45(5):639-44. PubMed ID: 17484627
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann DA; Barnes RB; Rosenfield RL; Cavaghan MK; Imperial J
Diabetes Care; 1999 Jan; 22(1):141-6. PubMed ID: 10333916
[TBL] [Abstract][Full Text] [Related]
8. Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis.
Zhu S; Zhang B; Jiang X; Li Z; Zhao S; Cui L; Chen ZJ
Fertil Steril; 2019 Jan; 111(1):168-177. PubMed ID: 30611404
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome in type 2 diabetes: does it predict a more severe phenotype?
Sim SY; Chin SL; Tan JL; Brown SJ; Cussons AJ; Stuckey BG
Fertil Steril; 2016 Oct; 106(5):1258-1263. PubMed ID: 27456547
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.
Legro RS; Kunselman AR; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 1999 Jan; 84(1):165-9. PubMed ID: 9920077
[TBL] [Abstract][Full Text] [Related]
11. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.
Ehrmann DA; Kasza K; Azziz R; Legro RS; Ghazzi MN;
J Clin Endocrinol Metab; 2005 Jan; 90(1):66-71. PubMed ID: 15507516
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI.
Flannery CA; Rackow B; Cong X; Duran E; Selen DJ; Burgert TS
Pediatr Diabetes; 2013 Feb; 14(1):42-9. PubMed ID: 22925367
[TBL] [Abstract][Full Text] [Related]
13. Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: a retrospective analysis.
Sharma ST; Wickham EP; Nestler JE
Endocr Pract; 2007; 13(4):373-9. PubMed ID: 17669713
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression.
Lim SS; Kakoly NS; Tan JWJ; Fitzgerald G; Bahri Khomami M; Joham AE; Cooray SD; Misso ML; Norman RJ; Harrison CL; Ranasinha S; Teede HJ; Moran LJ
Obes Rev; 2019 Feb; 20(2):339-352. PubMed ID: 30339316
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Predictors of Impaired Glucose Tolerance and Diabetes Mellitus Type 2 in Patients with Polycystic Ovary Syndrome.
Krstevska B; Mishevska SJ; Nakova VV; Serafimoski V
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Oct; 42(2):61-70. PubMed ID: 34699702
[No Abstract] [Full Text] [Related]
16. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of metabolic disturbances among women with polycystic ovary syndrome in different regions of Brazil.
Maffazioli GDN; Lopes CP; Heinrich-Oliveira V; Lobo RA; Hayashida SAY; Soares JM; Maciel GAR; Baracat EC
Int J Gynaecol Obstet; 2020 Dec; 151(3):383-391. PubMed ID: 32931592
[TBL] [Abstract][Full Text] [Related]
18. Metabolic inflexibility in women with polycystic ovary syndrome: a systematic review.
Rimmer M; Tan BK; Teede H; Thangaratinam S; H Al Wattar B
Gynecol Endocrinol; 2020 Jun; 36(6):501-507. PubMed ID: 31793357
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome.
Weerakiet S; Srisombut C; Bunnag P; Sangtong S; Chuangsoongnoen N; Rojanasakul A
Int J Gynaecol Obstet; 2001 Nov; 75(2):177-84. PubMed ID: 11684113
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS.
Pelanis R; Mellembakken JR; Sundström-Poromaa I; Ravn P; Morin-Papunen L; Tapanainen JS; Piltonen T; Puurunen J; Hirschberg AL; Fedorcsak P; Andersen M; Glintborg D
Hum Reprod; 2017 Nov; 32(11):2279-2286. PubMed ID: 29040530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]